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Previous research investigating the emotion recognition ability in patients with schizophrenia has mainly focused on the
recognition of facial expressions. To broaden our understanding of emotional processes in patients with schizophrenia, this
study aimed to investigate whether these patients experience and process other emotionally evocative stimuli diﬀerently from
healthy participants. To investigate this, we measured the cardiac and subjective responses of 33 male patients (9 with and 24
without antipsychotic medication) and 40 male control subjects to emotion-eliciting pictures. Cardiac responses were chosen
as an outcome measure because previous research has indicated that these are linked with attentional and emotional processes
and provide a more objective measure than self-report measures alone. The diﬀerences in cardiac responses between patients and
controls were limited tomedicated patients: only themedicated patients showed significantly decreased cardiac orienting responses
compared with control subjects, regardless of picture contents. These results indicate that medicated patients directed less attention
towards emotion-eliciting pictures than controls. Decreased attentional resources while processing emotional evocative stimuli
could lead to incorrect appraisals of the environment and may have detrimental emotional and social consequences, contributing
to chronic stress levels and an increased risk for cardiovascular disease.
1. Introduction
An extensive amount of research papers has been published
on the impaired emotional functioning of patients with
schizophrenia. Most of this research has focused on the
impaired ability of these patients to recognize emotions
from facial expressions [1], which is crucial for forming and
maintaining interpersonal relationships [2, 3], and patients
with schizophrenia are known to experience diﬃculties with
social functioning [4, 5].
Although schizophrenic patients seem impaired in their
ability to recognize and express emotional facial expressions,
they do appear to experience emotions in a way similar to
healthy controls. Several studies have found that patients
and controls did not diﬀer in their subjective ratings of
pleasantness and arousal when presented with emotion-
eliciting pictures [6–9]. In two other studies, schizophrenic
patients reported that they experienced the same amount of
pleasant emotions as healthy controls, but greater amounts
of unpleasant emotions in response to emotion-eliciting
stimuli [10, 11]. It has also been found that schizophrenic
patients experience less positive emotions and more negative
emotions in response to daily stressors [12] and emotion-
eliciting pictures [13], compared with healthy control
subjects. This apparent discrepancy between the impaired
ability of schizophrenic patients to recognize and express
emotional facial expressions, yet with intact experience
of emotions, needs further investigation. If schizophrenic
patients experience emotions in a way similar to healthy
control subjects, they are expected to perceive the emotion-
eliciting stimuli in a similar way as well. This could imply that
the disturbances in emotion recognition in schizophrenic
patients are restricted to facial stimuli, as opposed to more
general emotion-eliciting stimuli.
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Another aspect of emotions is the psychophysiological
response that accompanies them [14]. Psychophysiological
responses oﬀer a more objective measure of emotional
and cognitive processes than self-report alone. Only a few
studies have investigated the cardiac responses of patients
with schizophrenia during the viewing of emotion-eliciting
pictures. Two of these studies did not find any diﬀerences
between the patients and healthy controls with regard to
their cardiac responses [7, 9]. However, both studies used
the averaged heart rate response during slide viewing relative
to a 1- or 2-second baseline before picture onset, without
taking into account the triphasic pattern of the cardiac
response (deceleration-acceleration-deceleration [14]). Yee
et al. [15] did take this pattern into account and found that
only prodromal patients diﬀered significantly from healthy
controls and patients with schizophrenia in their heart rate
deceleration, that is, orienting response (OR), which was
more pronounced in these patients. In a study previously
conducted by our group [16], we found that patients with
schizophrenia hardly showed any OR to emotion-eliciting
pictures. Instead, we found a substantial increase in the heart
rate in patients with schizophrenia that was evoked by erotic
pictures, indicating an activation of the sympathetic nervous
system, which could either mean a defensive reaction to
these stimuli, suggesting stimulus rejection [17], or a strong
appetitive reaction. Summarizing, thus far mixed results
regarding cardiac responding in schizophrenia have been
reported. However, none of these studies have taken medica-
tion use into account, while it has previously been found that
atypical antipsychotics decrease physiological responding to
emotion-eliciting stimuli [18].
The aim of the present study is to broaden our knowledge
about the cardiac responding and underlying motivations of
patients with schizophrenia while viewing emotion-eliciting
pictures. Based on previous research [16], we hypothesized
that the patients with schizophrenia would show diminished
OR responses in general, reflecting a deficit in the intake
process of stimulus information. Because of the potential
importance of antipsychotic medication use on psychophys-
iological responses, we analysed our data separately for
medicated and antipsychotic-free patients, while controlling
for baseline levels of heart rate and heart rate variability,
smoking, mood, and age.
2. Methods
2.1. Subjects. In this study, 33 male patients with schizophre-
nia (9 antipsychotic free and 24 medicated) and 40 male
control subjects participated. The demographic details of
the participants are shown in Table 1. The patients were
recruited from the early psychosis unit at the Department
of Psychiatry of the Erasmus MC, University Medical
Center Rotterdam. All patients were screened by a senior
clinical psychiatrist using the Comprehensive Assessment of
Symptoms and History (CASH; [19]), and included in the
study if they were diagnosed as suﬀering from schizophrenia
according to the criteria of the DSM-IV [20]. All patients
experienced a psychotic episode at the time of the study. All
patients were inpatients and most of them were experiencing
their first psychotic episode or were receiving treatment
for the first time. In order to assess symptom severity, the
Dutch translation of the Positive and Negative Syndrome
Scale (PANSS; [21]) was used. As can be seen in Table 1,
antipsychotic-free patients had higher scores for all subscales
as well as the total score of the PANSS than medicated
patients (positive: t[28] = 2.4, P < 0.05; negative t[28] = 2.6,
P < 0.05; general psychopathology t[28] = 2.5, P < 0.05;
total score t[28] = 3.5, P < 0.01). The other diﬀerence
between these two groups was that the duration of illness was
significantly shorter in antipsychotic-free versus medicated
patients (t[25.96] = 3.3, P < 0.01).
Antipsychotic treatment was administered according to
the clinical treatment protocol of the Erasmus MC Clinic
for psychotic disorders, which is congruent with both the
schizophrenia treatment guidelines of the Dutch Psychiatric
Association and the American Psychiatric Association. The
details on medication use are shown in Table 2.
Controls were recruited by means of advertisements. All
controls were healthy and drug free at the time of testing
as assessed by means of a short phone interview and a
structured questionnaire. None of the controls or their first-
degree relatives had experienced past or current psychiatric
illnesses. Exclusion criteria for both patients and controls
were respiratory diseases, cardiovascular diseases, and the use
of medication that could influence the autonomic nervous
system. There were significantly more smokers in both
patient groups than in the control group (χ2 = 27.78, P <
0.001).
After the subjects were given a complete description
of the study, written informed consent was obtained. The
study was approved by the Medical Ethics Committee of the
ErasmusMC, University Medical Center Rotterdam, and was
carried out in accordance with the Declaration of Helsinki.
2.2. Procedure. All experimental sessions took place between
09.00 and 11.00 hrs in the morning. The subject sat in
a comfortable chair in a small, sound-attenuated dimly
lit room. The experimenter was in the room with the
participants at all times to ensure their safety and to
make sure they understood and complied with the task
instructions. Both patients and controls were asked not to
use any coﬀee or cigarettes before and during testing on the
day of the experimental session. Before the application of
the electrodes participants were asked to complete a Dutch
shortened version of the Profile of Mood States (POMS; [22].
Electrodes for the recordings of the heart rate were applied
according to the standard laboratory procedures. After the
application of the electrodes, the experimental session began
with a rest period of five minutes in which subjects were
asked to relax and not to speak. After this first rest period,
the headphones were put on and the emotional picture task
was explained. The duration of the task was approximately
25 minutes. After completion, all electrodes were removed
from the subjects and they were asked to do the subjective
rating task, which lasted approximately 15 minutes. All tasks
were designed using E-prime (Psychology Software Tools,
Inc., 2002).
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Table 1: Demographic characteristics of the patient and control groups.
Medicated patients (n = 24) Antipsychotic-free patients (n = 9) Controls (n = 40)
Age (mean ± Sd) 22 ± 4 21 ± 6 23 ± 4
Smokers (Yes/No)a 20/4 7/2 8/32
Duration of illness (months ± Sd)b 16 ± 19 3 ± 3
Duration of current medication use (weeks ± Sd) 4 ± 4
PANSSc (mean ± Sd)
Positive symptoms 17 ± 6 23 ± 6
Negative symptoms 15 ± 5 21 ± 5
General psychopathology 33 ± 9 43 ± 12
Total 65 ± 16 87 ± 14
PANSS: positive and negative syndrome scale; Sd: standard deviation.
aThere were significantly more smokers in both patient groups than in the control group (χ
2 = 27.78,P < 0.001).
b The duration of illness was significantly shorter in antipsychotic-free versus medicated patients (t[25.96] = 3.3,P < 0.01).
cAntipsychotic-free patients had higher PANSS scores for all subscales than medicated patients (positive: t[28] = 2.4,P < 0.05; negative t[28] = 2.6,P < 0.05;
general psychopathology t[28] = 2.5,P < 0.05; total score t[28] = 3.5,P < 0.01).
Table 2: Mean dosages and duration of current antipsychotic treatment of the patient group.
Antipsychotic n Mean dosage (mg) ± Sd Comedication
No Antipsychotic 9 Lorazepam (n = 3)
Olanzapine 8 16.3 ± 6.9 Lorazepam (n = 2)
Oxazepam (n = 1)
Risperidone 6 3.0 ± 0.8 Lorazepam (n = 1)
Oxazepam (n = 1)
Haloperidol 4 2.8 ± 1.5 Lorazepam (n = 2)
Clozapine 4 300.0 ± 81.6 Lorazepam (n = 3)
Quetiapine 2 450.0 ± 212.13 —
Sd: standard deviation.
2.3. Experimental Tasks
2.3.1. Emotional Picture Task. Subjects were seated approx-
imately 75 cm from the computer screen. All subjects were
asked to relax, to breathe regularly, and not to speak during
the task. The emotional picture task was a part of a larger
study in which we also investigated acoustic startle responses.
The subjects were told that they were about to view a series
of diﬀerent pictures and that loud noises were occasionally
presented through the headphones. They were asked to
look at the pictures the entire time they were presented
on the screen, but that they did not have to respond.
Forty-eight pictures were selected from the International
Aﬀective Picture System (IAPS [23]). (Positive IAPS pictures:
4220, 4290, 4608, 4660, 4670, 4680, 5260, 5470, 5621, 5910,
8030, 8170, 8490, 8501. Neutral IAPS pictures: 5120, 5260,
5510, 5530, 5535, 5711, 5731, 5740, 5900, 7000, 7002, 7004,
7006, 7009, 7010, 7020, 7025. Negative IAPS pictures: 3000,
3010, 3060, 3069, 3080, 3102, 3120, 3170, 6200, 6212, 6230,
6260, 6300, 6313, 6350, 6550.) The stimuli were chosen
on the basis of their normative ratings provided with the
IAPS and could be divided into six diﬀerent categories,
based on their contents. The positive pictures had erotic
and adventure contents, the neutral pictures showed nature
scenes and household objects, and the negative pictures
contained pictures with mutilation and threat contents. The
pictures were presented using a Dell Dimension M200a
Personal Computer with a Pentium processor and a 17-inch
Samsung SyncMaster monitor.
Each picture was presented during 6 seconds, with an
intertrial interval (ITI) ranging from 12 to 25 seconds. A total
of 48 pictures were presented; during 12 of these pictures (4
positive, 4 neutral, and 4 negative) no startle stimulus was
presented. During the remaining 36 pictures, startle stimuli
were presented either 300, 800, 1300, or 3800ms after picture
onset in such a way that each of these latency conditions
occurred 3 times during the viewing of positive, neutral,
and negative pictures. In addition, 12 startle stimuli were
randomly presented during the inter trial intervals. Thus, a
total of 48 pictures and 48 startle stimuli were presented.
All pictures and startle stimuli were presented completely at
random so that each subject was presented with a diﬀerent
order of stimuli. For the purpose of this paper, we will
only report the cardiac responses to the pictures that were
presented without a startle stimulus.
2.3.2. Subjective Rating Task. The pictures that were pre-
sented during the startle task were again presented in the
subjective rating task, using a randomized order diﬀerent
from that of the startle task. The participants were asked to
rate how they felt during the viewing of the pictures. They
responded with their dominant hand using the numbers
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on the keyboard. A fixation cross was presented for 3
seconds on a 17-inch computer screen, followed by a 6-
second presentation of a picture. After picture oﬀset, the
subjects were asked to rate each picture using the SAM
(Self-Assessment Manikin; [24]. The SAM consisted of two
subsequent screens, each containing five figures. On the first
screen, the figures represented the degree of pleasantness
of the pictures—ranging from very unpleasant to very
pleasant—on a scale from 1 to 9. On the second screen, each
figure represented the degree of arousal associated with each
picture—ranging from very calm to very arousing—also on
a scale from 1 to 9. After their response, the fixation cross
appeared again for 3 seconds, followed by the next picture.
2.3.3. Cardiac Responses. During the experiment, continu-
ous measurements were made of the heart rate (HR). HR
was recorded using a precordial lead and was sampled at
512Hz. All data were sampled and stored on a flashcard
by means of a portable digital recorder (Vitaport System;
TEMEC Instruments B.V., Kerkrade, The Netherlands).
Upon completion of the recording, all physiological data
were imported and processed on a Personal Computer
using a Vitascore software module (TEMEC Instruments
BV, Kerkrade, The Netherlands). Subsequently, the interbeat
intervals were calculated using R-top detection. A low pass
filtered cardiac event series (LPFCES; [25]) was calculated,
using a low pass filter of 0.5Hz. This method is based on the
Integral Pulse Frequency Modulation model [25].
The responses to the 12 pictures that were presented
without a startle stimulus were used for the analyses of the
cardiac responses. Data series for each individual stimulus
were extracted for the pictures starting 2 seconds before stim-
ulus onset and ending 6 seconds after stimulus onset. Cardiac
responses for each stimulus were calculated by subtracting
the 6 seconds after stimulus onset from the 2-second baseline
period before each stimulus. This resulted in time series
consisting of diﬀerence scores for each separate stimulus.
2.3.4. Baseline HR and Heart Rate Variability (HRV). Mean
HR was calculated over a 3-minute period of rest. Addi-
tionally, this HR time series was subjected to a discrete
Fourier transform (CARSPAN program, Groningen, The
Netherlands [26, 27]), to yield power spectra of the rhythmic
oscillations over a frequency range of 0.02–0.50Hz, with
a resolution of 0.01Hz. The power was calculated for the
high frequency band (HF-HRV: 0.15–0.5Hz). Because of
the skewed distribution, a natural log transformation was
applied to HF-HRV.
2.4. Statistical Analyses. All analyses were conducted using
SPSS version 13.0 andMlWin 2.10 [28]. All alpha’s were set at
0.05 unless otherwise specified. All self-report responses were
used as a manipulation check and to make sure participants
had complied with the task instructions.
2.4.1. Profile of Mood States (POMS). To investigate the
subjective mood state of the participants at the time of
testing, we analysed their POMS scores using nonparametric
tests. To assess whether there were any diﬀerences between
the three groups (medicated, antipsychotic free, and con-
trols), the Kruskal-Wallis test was used. When significant
diﬀerences were found, we proceeded to investigate which
groups diﬀered from each other using the Mann-Whitney
tests and to correct for multiple testing, the alpha was
reduced to 0.016. The maximal scores for each of the scales
were as follows: depression 32, fatigue 24, tension 24, anger
28, and vigour 20. The TotalMoodDisturbance (TMD) score
was calculated by subtracting the vigour score from the sum
of all the other scores (i.e., depression + fatigue + tension
+ anger − vigour = TMD), so that a higher positive score
represented a more negative mood state.
2.4.2. Cardiac Responses
Baseline. The mean HR level and the ln(HF-HRV) of the
three groups during 3 minutes of resting baseline before
the onset of the tasks were compared using an analysis of
variance (ANOVA) with Group (medicated, antipsychotic-
free, and controls) as the between subjects factor.
Cardiac Response to Picture Stimuli. For the analysis of
cardiac responses to the emotional stimuli, we developed
an hierarchical linear model (HLM) using MlWin software
[28], with Subject, Time, and Picture Type entered as
repeated variables. The fixed factors in the HLM were
Group (medication free, medicated, and control), Time (0–
6 seconds, in half second bins) with its linear and quadratic
polynomials, Picture Type (negative, neutral, and positive),
Group × Time, Group × Picture Type, Time × Picture Type,
and Group × Time × Picture Type. The following covariates
were entered smoking (number of cigarettes per day), age,
illness duration (months), medication duration (weeks),
POMS TMD score, baseline ln(HF-HRV), and baseline HR.
We also entered the following interaction eﬀects: ln(HF-
HRV) × Time and baseline HR × Time; these were included
to examine whether they were related to a diﬀerent cardiac
responding to startle stimuli, since we previously found that
schizophrenic patients generally experience decreased levels
of HF-HRV [29], which could explain overall decreased
cardiac responsivity to stimuli. All factors and covariates
were entered in the model and the best fit for the model was
sought using the log-likelihood method. Significant interac-
tion eﬀects were followed up by separate linear models.
2.4.3. SAM Ratings. Since the Kolmogorov-Smirnov tests
indicated that the distributions of the SAM rating of pleasure
and arousal were normally distributed within the groups (P
values ranged from 0.13 to 1.00), we performed two repeated
measures ANOVA’s with Pleasure or Arousal rating as the
dependent variable, Group (medicated, antipsychotic-free
and controls) as the between subjects factor, and Picture Type
as the within subjects factor.
3. Results
3.1. Profile of Mood States (POMS). The POMS scores of the
three groups are reported in Table 3. Because the Kruskal-
Wallis test showed that there were significant diﬀerences
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Table 3: Profile of mood states scores per group.
Medicated patients (n = 24) Antipsychotic-free patients (n = 9) Controls (n = 40)
POMS mean ± Sd (range)
Depression 7 ± 7 (0–22)∗ 8 ± 9 (0–28)∗ 1 ± 2 (0–6)
Fatigue 6 ± 6 (0–18) 8 ± 5 (1–15)∗ 3 ± 3 (0–11)
Tension 6 ± 5 (0–16)∗ 6 ± 4 (0–12)∗ 2 ± 2 (0–9)
Anger 5 ± 5 (0–17)∗ 7 ± 5 (0–16)∗ 1 ± 2 (0–10)
Vigour 11 ± 5 (2–18) 7 ± 5 (0–13)∗ 12 ± 3 (5-18)
TMD 12 ± 20 (−15–60) ∗ 21 ± 22 (2–68)∗ −5 ± 7 (−14–14)
Sd: standard deviation; TMD: total mood disturbance; ∗significant diﬀerence compared to controls, P < 0.01.
between the three groups in mood scores (depression χ22 =
28.0, P < 0.001; fatigue χ22 = 9.7, P < 0.01; tension χ22 = 22.0,
P < 0.001; anger χ22 = 16.9, P < 0.001; vigor χ22 = 6.8,
P < 0.05; TMD score χ22 = 23.2, P < 0.001), we used
the Mann-Whitney tests to further explore these diﬀerences.
The medicated and antipsychotic-free patients did not diﬀer
significantly in their mood scores for any of the subscales
(all P’s were 0.10 or higher). However, compared to control
subjects, the antipsychotic-free patients showed significantly
decreasedmood on all subscales and the TMD score (all P’s <
0.01), and the medicated patients had significantly decreased
mood scores for depression, tension, anger, and the TMD
score (all P’s < 0.001).
3.2. Heart Rate and HF-HRV at Baseline. Data was lost for
one medicated patient due to excessive movements during
baseline. We found a significant Group eﬀect when we
investigated whether the resting HR of patients who were
not under current antipsychotic medication (n = 9) and
medicated patients (n = 23) diﬀered from the resting HR
of the control group (n = 40), F[2, 69] = 8.26, P = 0.001,
partial η2 = 0.19. The mean HR of medicated patients was
83 ± 16 bpm, of antipsychotic-free patients 75 ± 13 bpm,
and of controls 69 ± 11 bpm. The Bonferroni post hoc tests
indicated that only the mean HR of the medicated patients
was significantly higher than that of the control subjects
(mean diﬀerence = 14.05, sd = 3.46, P < 0.001).
We also found a significant Group eﬀect for the natural
logarithm of HF-HRV, F[2, 69] = 6.07, P < 0.01, partial η2 =
0.15. The Bonferroni post-hoc test (mean diﬀerence = 1.08,
sd = 0.31, P < 0.01) showed that medicated patients had a
significantly lower HF-HRV (6.21 ± 1.59) than the control
subjects (7.29 ± 0.92), while the antipsychotic-free patients
did not diﬀer significantly from either groups (7.18± 1.17).
3.3. Cardiac Response to Picture Stimuli. The following
factors did not contribute significantly to the model and
were therefore removed: the three-way interaction between
Group× Time× Picture Type, Smoking, and the interaction
between baseline HR × Time.
All beta-coeﬃcients for this model are reported in
Table 4, and the cardiac responses of each of the three
groups are shown in Figures 1(a)–1(c). The significant main
eﬀect for Group (joint χ2(1) = 94.41, P < 0.01) indicated
that all three groups diﬀered from each other in terms of
overall HR level: with all other variables being constant, the
medicated patients showed the least deceleration, followed
by the controls, while the antipsychotic-free patients showed
the most deceleration overall. As expected, the main eﬀect
for Picture Type (joint χ2(1) = 11.04, P < 0.01) indicated that
the HR decelerations were significantly larger for negative
and positive pictures compared to neutral pictures. The
significant main eﬀect of Time linear showed that HR
decreased over time.
The significant interaction eﬀect of Group × Picture
Type (joint χ2(1) = 23.50, P < 0.01) indicated that the HR
responses to the various picture types of the patient groups
were less diﬀerentiated than the HR responses of the control
group. For example, the diﬀerence in HR deceleration
between negative and neutral pictures was smaller in the
medicated group compared to the control group, while the
diﬀerence in HR response between positive and neutral pic-
tures was smaller in the antipsychotic-free group compared
to the control group. Also, the medicated patients showed
more HR deceleration to positive versus negative pictures,
whereas both the antipsychotic-free patients and the controls
did not. The significant interaction eﬀect of Group × Time1
(joint χ2(1) = 10.80, P < 0.01) indicated that medicated
patients showed significantly less HR deceleration over time
than antipsychotic-free patients and healthy controls. The
Picture Type by Time1 (joint χ2(1) = 24.98, P < 0.01)
interaction eﬀect confirmed that HR decelerates more over
time for negative and positive pictures than neutral pictures.
With regard to the covariates, the significant eﬀect of
Age indicated that the HR increased with age, whereas
the significant eﬀects of duration of medication use and
illness duration indicated more deceleration with longer
antipsychotic medication use and/or longer illness duration.
We also found that Baseline HR was negatively related to
cardiac response: a higher HR at baseline is related to more
HR deceleration during picture viewing, and ln(HF-HRV)
significantly interacted with Time1, indicating that increases
in cardiac vagal activity during rest were related to an
increased cardiac response. Finally, increased negative mood
was related to a cardiac increase, as shown by the significant
eﬀects of the POMS TMD score.
3.4. Follow-Up Analyses per Group. Because of the significant
two-way interaction eﬀects with Group and because the
figures suggested a decreased orienting response in the
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Table 4: Beta coeﬃcients of the HLM for cardiac responses to emotion-eliciting pictures in medication free patients, medicated patients,
and healthy control subjects.
Factor Comparison between GroAFPs Comparison between picture types Beta coeﬃcient Standard error Z-score∗
Constant −0.13 1.11 −0.12
AFP versus C −0.88 0.43 −2.04
Group MP versus C 1.60 0.36 4.51
MP versus AFP 2.51 0.45 5.57
Neg. versus Neu. −2.12 0.24 −8.76
Picture type Pos. versus Neu. −1.79 0.24 −7.39
Pos. versus Neg. 0.33 0.24 1.37
Time1 −5.63 1.72 −3.27
Time2 −0.03 1.72 −0.02
AFP versus C Neg. versus Neu. 0.59 0.56 1.05
MP versus C Neg. versus Neu. 1.54 0.40 3.86
MP versus AFP Neg. versus Neu. 0.92 0.60 1.54
AFP versus C Pos. versus Neu. 1.65 0.56 2.93
Group × Picture Type MP versus C Pos. versus Neu. 0.69 0.40 1.72
MP versus AFP Pos. versus Neu. −1.02 0.60 −1.71
AFP versus C Pos. versus Neg. 1.06 0.56 1.89
MP versus C Pos. versus Neg. −0.86 0.40 −2.15
MP versus AFP Pos. versus Neg. −1.92 0.60 −3.20
AFP versus C −0.60 0.83 −0.72
Group × Time1 MP versus C 1.85 0.64 2.92
MP versus AFP 2.46 0.91 2.70
AFP versus C −0.69 0.83 −0.83
Group × Time2 MP versus C −1.00 0.64 −1.57
MP versus AFP −0.30 0.91 −0.33
Neg. versus Neu. −3.15 0.65 −4.85
Picture Type × Time Pos. versus Neu. −2.26 0.65 −3.48
Pos. versus Neg. 0.90 0.65 1.38
Neg. versus Neu. 0.26 0.65 0.40
Picture Type × Time Pos. versus Neu. 0.37 0.65 0.56
Pos. versus Neg. 0.11 0.65 0.17
Age 0.10 0.02 4.95
Medication duration −0.17 0.03 −5.09
Illness duration −0.02 0.01 −2.88
HR baseline −0.03 0.01 −3.71
Ln(HRV HF) −0.09 0.08 −1.09
Ln(HRV HF) × Time1 0.82 0.23 3.62
Ln(HRV HF) × Time2 0.18 0.23 0.79
POMS TMD score 0.01 0.01 2.33
∗
Numbers expressed in bold indicate significant eﬀects at the 0.05 level.
HR: heart rate; Ln(HF-HRV): natural logarithm of high frequency heart rate variability; POMS: profile of mood states; TMD: total mood disturbance;
AFP: antipsychotic-free patients; C: control; MP: medicated patients; Neg: negative pictures; Neu: neutral pictures; Pos: positive pictures.
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Figure 1: Time series of mean cardiac responses to negative, neutral, and positive picture stimuli in (a) antipsychotic-free patients, (b)
medicated patients, and (c) healthy control participants during the 6 seconds of picture presentation.
patient groups to positive and negative compared to neutral
pictures, we further investigated this with follow-up HLM
models for each group, only including the cardiac responses
during the first 3 seconds of picture viewing.
Within the antipsychotic free patient group, the Time ×
Picture Type interaction eﬀect was significant (joint χ2(1) =
9.31, P < 0.01), indicating that the heart rate decreased
more over time for negative than for positive pictures, that
is, the antipsychotic-free patients showed a larger orienting
response to negative versus positive pictures. Within the
medicated patient group, the main eﬀect for Picture Type
was significant (joint χ2(1) = 5.33, P < 0.01), indicating that
the heart rate of the medicated patients was lower during
the first 3 seconds for positive compared to neutral pictures.
Within the control group, the main eﬀects for Time (Z =
−3.92, P < 0.01) and Picture Type (joint χ2(1) = 22.47, P <
0.01). As can be seen in Figure 1(c), the HR of the controls
decreased more for positive and negative than for neutral
pictures. The interaction eﬀect of Time× Picture Type (joint
χ2(1) = 6.30, P < 0.01) was also significant, although pairwise
comparisons were not.
3.5. Subjective Ratings. In Figures 2(a) and 2(b), the mean
SAM ratings for pleasure and arousal are presented. For
the pleasure ratings, we found a significant main eﬀect for
Picture Type (F[1.7; 121.6] = 178.88, P < 0.001, partial
η2 = 0.72). The positive pictures were rated as most
pleasant, followed by the neutral pictures, and the negative
pictures were rated as least pleasant (positive versus neutral:
F[1, 71] = 47.32, P < 0.001, partial η2 = 0.40; positive versus
negative: F[1, 71] = 296.50, P < 0.001, partial η2 = 0.81;
neutral versus negative: F[1, 71] = 136.00, P < 0.001, partial
η3 = 0.66). No significant main or interaction eﬀects for
Group were found.
For the arousal ratings a significant main eﬀect for
Picture Type was found (F[1.6; 108.5] = 28.68, P < 0.001,
partial η2 = 0.29). The negative and positive pictures were
rated as more arousing than the neutral pictures, whereas
no diﬀerence in arousal ratings was found between positive
and negative pictures (negative versus positive: F[1, 70] =
1.23, P = 0.27; negative versus neutral: F[1, 70] = 39.38,
P < 0.001, partial η2 = 0.36; positive versus neutral:
F[1, 71] = 74.17, P < 0.001, partial η2 = 0.51). The main
eﬀect for Group was also significant (F[2, 70] = 3.61, P <
0.05, partial η2 = 0.09). The Games-Howell test showed
that the arousal ratings of the medicated patients group
tended to be higher than those of the antipsychotic-free and
control groups (medicated versus antipsychotic-free: mean
diﬀerence = 0.98, sd = 0.44, P = 0.09; medicated versus
control: mean diﬀerence = 0.83, sd = 0.37, P = 0.07). The
interaction eﬀect between Picture Type and Group almost
reached significance (F[3.1; 108.5] = 2.49, P = 0.06, partial
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Figure 2: (a) Pleasure and (b) Arousal ratings of antipsychotic-free patients, medicated patients, and healthy control subjects for positive,
neutral, and negative pictures.
η2 = 0.07). The antipsychotic-free patients tended to show
less diﬀerentiation in arousal ratings between the negative
and neutral, and positive and neutral pictures compared
with both the medicated and control groups (negative versus
neutral: F[2, 70] = 3.87, P < 0.05, partial η2 = 0.10; positive
versus neutral: F[2, 70] = 3.46, P < 0.05, partial η2 = 0.09).
4. Discussion
The aim of this study was to investigate whether male
patients with schizophrenia diﬀered from healthy control
subjects in their psychophysiological responses to emotion-
eliciting pictures. A distinction was made between patients
who were taking antipsychotic medication and patients who
were not.
While the healthy control subjects and antipsychotic-free
patients showed the expected triphasic pattern (i.e., decrease-
increase-decrease) for cardiac responses to positive and
negative pictures—albeit somewhat less pronounced for pos-
itive pictures in antipsychotic-free patients—the medicated
patients did not show an initial decrease for any of the picture
types, suggesting a lack of orientation towards the pictures.
The orientation response (OR), the initial deceleration of the
heart rate, is considered to be the basic cardiac response to
perceptual stimuli and tends to be greatest for unpleasant
pictures. The cardiac OR is thought to reflect the intake of
stimulus information [30–32]. Our results suggest that in
medicated patients with schizophrenia this OR is lacking
a finding that is consistent with the existing literature on
attentional deficits in these patients [33–35]. However, we
did not find this lack of OR in antipsychotic-free patients.
It seems paradoxical that the antipsychotic-free patients
showed overall decreased mood scores and more severe
symptom scores yet physiologically they seemed to respond
more similarly to healthy control subjects than themedicated
patients. A number of factors could account for this finding.
First, a diﬀerence in sympathovagal balance in the patient
group could account for the diﬀerence in ORs. Previous
studies have consistently found a decrease in cardiovagal con-
trol in patients with schizophrenia, regardless of medication
status [36–40]. Indeed, we found that the power of high
frequency HRV was lower in medicated patients compared
with healthy control subjects, but not antipsychotic-free
patients. The initial HR deceleration related to orienting
is generally considered to be under vagal control [41–43].
The autonomic nervous system (ANS) is considered the link
between the central nervous system and the body, and so the
ANS mediates the relationship between centrally occurring
events such as emotions and bodily changes such as heart rate
variability [44]. Thus, generally reduced cardio-vagal control
in patients may have caused the reduced OR rather than this
being a result of decreased emotional experience or attention
in response to emotion-eliciting pictures. However, after
controlling for reduced cardio-vagal control by including
HRV as a covariate in our analyses the diﬀerences between
the medicated and control groups were still significant,
suggesting that a diﬀerence in central processing was at
least partially responsible for the diﬀerent cardiac responses
between groups.
Second, the sample size for the antipsychotic-free
patients was very small, so the lack of a significant diﬀerence
between antipsychotic-free patients and healthy control
subjects could be due to a lack of statistical power. Although
we cannot rule out this possibility, Figures 1(a)–1(c) suggest
that antipsychotic-free patients had heart rate decelerations
during picture viewing comparable to controls, and a
previous study [15] showed an almost identical pattern of
cardiac responses to emotion-eliciting pictures in a group of
prodromal patients (n = 12, of which 8 are antipsychotic
free). Third, the use of antipsychotic medication may have
caused side eﬀects such as sedation and/or drowsiness.
However, the medicated patients did not diﬀer significantly
in their subjective fatigue and vigour scores of the POMS
when compared to healthy controls. Thus, a number of
factors could have caused this diﬀerence between medicated
and antipsychotic-free patients, but with our current data we
are unable to answer this question satisfactorily. We therefore
propose that future research should focus more on the
diﬀerence in emotional responding between medicated and
Cardiovascular Psychiatry and Neurology 9
antipsychotic-free patients with schizophrenia to disentangle
medication side eﬀects from emotional processing deficits.
Medicated and antipsychotic-free patients diﬀered signif-
icantly with regard to the subjective arousal ratings of the
pictures. Medicated patients tended to show overall higher
arousal ratings than antipsychotic-free patients and controls,
a finding that is in line with the previous study of Schlenker
et al. [7]. We also found that antipsychotic-free patients
showed less diﬀerentiation in their arousal scores of neutral
versus negative and positive pictures than medicated patients
and healthy controls. Whether this finding is caused by
increased arousal ratings to neutral pictures or decreased
arousal ratings to positive and negative pictures is not clear at
the moment. All three groups rated the pictures similarly in
terms of pleasure, with positive pictures receiving the highest
and unpleasant pictures receiving the lowest pleasure scores.
There were some limitations to our study. For example,
we only included male participants in this study, which
reduces the generalization of our results. Also, we did not
diﬀerentiate between paranoid and nonparanoid patients
in our analyses. Rather, we chose to investigate a more
heterogeneous patient sample to be able to generalize our
results to a patient population that suﬀered from recent-
onset schizophrenia, regardless of specific symptoms, that is,
patients with predominantly positive, negative, or disorga-
nized symptoms were all included in this study.
As it is a common practice in studies investigating
psychophysiological responses to emotion-eliciting pictures,
we sampled and analysed the cardiac responses only for
the time period in which the picture was presented, that
is, for 6 seconds. However, because we did not analyse the
cardiac responses after picture oﬀset it is possible we have
missed potential diﬀerences between groups. Previous stud-
ies measuring diﬀerent types of responses (i.e., behavioural,
startle, and fMRI) have found evidence to suggest that
although patients’ responses do not diﬀer from healthy
control subjects while an emotionally evocative stimulus is
present, they do appear to have diﬃculties in maintaining
the elicited emotional response once the stimulus disappears
[45–47], thereby reducing their ability to use emotions to
help them select the most appropriate behavioural response.
Because we asked our participants to give their subjective
ratings immediately after picture oﬀset we were unable to
analyse the responses after picture oﬀset. Future studies
should allow for the investigation of maintained emotional
and physiological responses to increase our understanding
of the emotional and motivational challenges patients with
schizophrenia experience.
One potential weakness of this study is that, like most
studies investigating cardiac responses to picture stimuli,
we did not control for respiration. Asking participants to
pace their breathing would have been too demanding and
would have confounded our results. In addition, opinions
with regard to the usefulness and validity of controlling
respiration while measuring cardiac vagal control and/or
cardiac responses are divided [48–50]. We tried to control for
respiratory sinus arrhythmia by entering HRV as a covariate
but a more sophisticated within-subject analysis beyond
the scope of this study would be required to control for
respiratory variations in the cardiac time series [48].
5. Conclusions and Implications
Our results indicate that the main diﬀerence between
patients with schizophrenia and healthy control subjects lies
in the reduced amount of attentional resources available in
medicated patients while viewing emotion-eliciting pictures.
No interaction eﬀects between emotional picture contents
and groups were found, indicating that this is a general eﬀect
and not caused by any specific picture content. These results
are in line with previous studies in which no diﬀerences
in cardiac responding between patients and controls were
found [7, 9].
We replicated our previous findings regarding the lack of
orienting responses in patients with schizophrenia [16]. The
decreased OR we found in our patient sample is in line with
findings that patients with schizophrenia gather little infor-
mation before responding to certain tasks, a response style
termed “jumping to conclusions” [51, 52]. Abnormalities
in the identification of emotionally salient information may
lead to misinterpretations of the intentions of others, which
may increase or exacerbate paranoid thoughts and result in
dysfunctions in social behaviour [53].
Medicated patients also showed emotionally dampened
responses: that is, not only did they show a reduced or absent
OR but they also had less diﬀerentiation in their responses to
the emotion-eliciting pictures. McCubbin et al. [54] propose
that emotional dampening could increase psychological
distress via inappropriate social interactions with family
members, friends, and coworkers. In addition, emotional
dampening has been found to be related to increased risk for
cardiovascular disease, most notably hypertension [54].
Summarizing the combination of decreased stimulus
intake, jumping to conclusions and emotional dampening
can all contribute to chronic stress levels in patients with
schizophrenia, resulting in diﬃculties in social and emo-
tional functioning and an increased risk for cardiovascular
disease.
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